Anti-ZPBP2/ ZPBPL functional antibody
Anti-ZPBP2/ ZPBPL functional antibody for cell culture, ELISA & in-vivo assay
Go to ZPBP2/ZPBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1389-Ab-1/ GM-Tg-hg-SE1389-Ab-2 | Anti-Human ZPBP2 monoclonal antibody | Human |
GM-Tg-rg-SE1389-Ab-1/ GM-Tg-rg-SE1389-Ab-2 | Anti-Rat ZPBP2 monoclonal antibody | Rat |
GM-Tg-mg-SE1389-Ab-1/ GM-Tg-mg-SE1389-Ab-2 | Anti-Mouse ZPBP2 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1389-Ab-1/ GM-Tg-cynog-SE1389-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ZPBP2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1389-Ab-1/ GM-Tg-felg-SE1389-Ab-2 | Anti-Feline ZPBP2 monoclonal antibody | Feline |
GM-Tg-cang-SE1389-Ab-1/ GM-Tg-cang-SE1389-Ab-2 | Anti-Canine ZPBP2 monoclonal antibody | Canine |
GM-Tg-bovg-SE1389-Ab-1/ GM-Tg-bovg-SE1389-Ab-2 | Anti-Bovine ZPBP2 monoclonal antibody | Bovine |
GM-Tg-equg-SE1389-Ab-1/ GM-Tg-equg-SE1389-Ab-2 | Anti-Equine ZPBP2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1389-Ab-1/ GM-Tg-hg-SE1389-Ab-2; GM-Tg-rg-SE1389-Ab-1/ GM-Tg-rg-SE1389-Ab-2; GM-Tg-mg-SE1389-Ab-1/ GM-Tg-mg-SE1389-Ab-2; GM-Tg-cynog-SE1389-Ab-1/ GM-Tg-cynog-SE1389-Ab-2; GM-Tg-felg-SE1389-Ab-1/ GM-Tg-felg-SE1389-Ab-2; GM-Tg-cang-SE1389-Ab-1/ GM-Tg-cang-SE1389-Ab-2; GM-Tg-bovg-SE1389-Ab-1/ GM-Tg-bovg-SE1389-Ab-2; GM-Tg-equg-SE1389-Ab-1/ GM-Tg-equg-SE1389-Ab-2 |
Products Name | Anti-ZPBP2 monoclonal antibody |
Format | mab |
Target Name | ZPBP2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ZPBP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1389-Ag-1 | Recombinant multi-species ZPBP2/ ZPBPL protein |
ORF Viral Vector | pGMLP003346 | human ZPBP2 Lentivirus plasmid |
ORF Viral Vector | vGMLP003346 | human ZPBP2 Lentivirus particle |
ORF Viral Vector | pGMLPm001284 | mouse Zpbp2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001284 | mouse Zpbp2 Lentivirus particle |
Target information
Target ID | GM-SE1389 |
Target Name | ZPBP2 |
Gene ID | 124626,69376,363676,698217,480531,101101601,514334,100068017 |
Gene Symbol and Synonyms | 1700017D11Rik,2610022C02Rik,ZPBP2,ZPBPL |
Uniprot Accession | Q6X784,Q6X782 |
Uniprot Entry Name | ZPBP2_HUMAN,ZPBP2_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000186075 |
Target Classification | N/A |
The target: ZPBP2, gene name: ZPBP2, also named as ZPBPL. Predicted to be involved in acrosome assembly and binding activity of sperm to zona pellucida. Predicted to act upstream of or within membrane lipid metabolic process and regulation of gene expression. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.